Stress In The Canadian Workplace

Almost Half of Canadian Benefit Plan Members are Highly Stressed at Work
Women and Public Sector Employees are More Likely to Feel Stressed on the Job

Montrйal, Quйbec, May 16, 2000 - A new, nationwide survey on healthcare sponsored by Aventis Pharma and released today found that 47 per cent of employed Canadians with a health benefit plan say they face "a great deal of stress at work". Among respondents to the survey, women and public sector employees are the most likely to say they feel stressed on the job.

Among other key findings, the survey revealed that 26 per cent of respondents said that "stress in the workplace has made them physically ill at times", and 11 per cent said they "book more time off work" because of stress. Forty-one per cent of respondents said "employers are not doing enough to help their employees deal with stress".

"This year's survey establishes a link between workplace stress and employee absenteeism," said Sanjiv Sharma, Director, Health Policy, Strategic Planning, Aventis Pharma. "It clearly shows that stress generates significant costs for employers in terms of loss of productivity."

"Clearly, this is a problem that affects both employers and employees. And it will be through dialogue and cooperation that effective and efficient methods of combating job-related stress will be found," said Dr. Yves Lamontagne, President of the Collиge des mйdecins du Quйbec. Dr. Brian Bexton, President of the Quйbec Psychiatrists Association, agrees. "Stress can degenerate into physical or mental problems and the prevention of stress in the workplace should be made a priority in order to avoid these costly diseases," he said.

In addition to the findings on stress in the workplace, the survey revealed that all private health plan benefits are highly valued. Drug coverage is the most important, with 94 per cent of plan members saying it is either "somewhat" (23%) or "very" (71%) important.

This year's survey also detected for the first time a shift in plan members' attitudes towards the public healthcare system. Still seen by most (81%) as providing medical services of "good", "very good" or "excellent" quality, a strong majority (71%) now believe the system has worsened in the past two years.

"Aventis Pharma's objective in sponsoring this survey is to give the close to nine million Canadians who are members of company health benefit plans a voice as well as to give plan managers accurate information on the needs of their customers," stated Michel Giroux, Vice-President, External Affairs and Public Relations at Aventis Pharma. "Hopefully, the study's findings will arm plan managers with useful and accurate information which they can then use to improve health plans for the benefit of consumers."

Plan Members are Satisfied with Their Coverage

The survey found that most (68%) Canadian plan members say their health benefit plan meets their needs either "very" or "extremely" well. "Despite the challenge of managing private plans under continuous cost pressures, employers and other plan sponsors have been successful in maintaining consumer's satisfaction levels of 68 per cent," said Mr. Sharma.

Asked if they want access to new relatively expensive research-based medications, eight in ten (80%) say they believe it is important (i.e. rate six or higher on a 10-point scale) that "employee health plans cover any new drugs that are available regardless of their cost". Three-quarters (75%) of respondents said they would also be willing to pay higher premiums to guarantee that their health benefit plan covers these new medications.

The survey found that amongst benefit plan members, there is no consensus on how the public healthcare system should be funded. When offered the choice between the current taxpayer-funded system and a system funded by a combination of taxes and user fees, 44 per cent chose the status quo and 55 per cent endorsed a system which combines taxpayer money and user fees.

More Stress Among Women and the Public Sector

The survey indicates a relationship between stress and demographics such as gender, province and workplace environment.

According to the survey's findings, there is a higher incidence of job-related stress in Alberta (53%), British Columbia (52%) and Ontario (51%), and among women (53%), public sector employees (53%), people aged 35-54 (49%), divorced or widowed individuals (54%), university graduates (50%) and high-income earners (50%). At the opposite end of the spectrum, there is a lower incidence of work-related stress in Quйbec (39%), and among men (41%), the self-employed (38%), people aged 55 or older (41%), individuals who are married or living in common law (44%), high school graduates (43%) and those earning $30,000 or less annually (42%).

Respondents indicated that workload (43%) and meeting personal financial responsibilities (35%) are their primary sources of stress. Balancing work with home or personal life (32%) and the workplace environment in general (26%) are sources of stress for at least a quarter of respondents.

The Angus Reid Group conducted telephone interviews across Canada between February 10, 2000 and March 2, 2000, with a random sample of 1,506 primary group insurance plan members who had a medical benefit component to their plan. With such a sample, one can say with 95 per cent certainty that the results are within plus or minus 2.5 percentage points of what they would have been had the entire population of group insurance plan members been polled.

Aventis Pharma Inc. is the Canadian pharmaceutical business of Aventis S.A., one of the world's leading life sciences companies focusing on two core areas - pharmaceuticals and agriculture.

Aventis Pharma is dedicated to treating and preventing human disease through the discovery, development, manufacture and sale of innovative pharmaceutical products aimed at satisfying unmet medical needs. The corporate headquarters of Aventis Pharma is in Frankfurt, Germany. The Canadian operations employ 690 people and are headquartered in Laval, Quйbec.

For more information on this news release, please contact:

Michael Tremblay
Aventis Pharma Inc.
(514) 956-4098

Guy Leroux
Aventis Pharma Inc.
(514) 393-1180 (ext. 131)

Related news